. 2018 Aug 16;8(3):91–94. doi: 10.1556/1886.2018.00001

Table 2.

DST pattern of clinical isolates

GeneXpert MTB/RIF assay results	Drug resistance pattern	New cases (n = 130)	Previous treated patients (n = 32)
MTB detected and rifampicin susceptible	RIF^S + INH^S+ STR^S + EMB^S + AMK^S + OFX^S	85	7
	RIF^S + INH^S+ STR^R + EMB^S + AMK^S + OFX^S	1	4
	RIF^S + INH^R+ STR^S + EMB^S + AMK^S + OFX^S	8	2
	RIF^S + INH^R+ STR^R + EMB^S + AMK^S + OFX^S	4	1
MTB detected and rifampcin resistant	RIF^S + INH^R+ STR^R + EMB^S + AMK^S + OFX^S	1	2
	RIF^S + INH^R + STR^R + EMB^R + AMK^S + OFX^S	5	–
	RIF^R + INH^R + STR^S + EMB^S + AMK^S + OFX^S	5	1
	RIF^R + INH^R + STR^R + EMB^S + AMK^S + OFX^S	5	5
	RIF^R + INH^R + STR^R + EMB^R + AMK^S + OFX^S	14	7
	RIF^R + INH^R + STR^S + EMB^R + AMK^S + OFX^S	2	1
	RIF^R + INH^R + STR^S + EMB^R + AMK^S + OFX^R (pre-XDR-TB)	–	1
	RIF^R + INH^R + STR^R + EMB^S + AMK^S + OFX^R (pre-XDR-TB)	–	1

RIF^S: rifampin susceptible; RIF^R: rifampin resistant; INH^S: isoniazid susceptible; INH^R: isoniazid resistant; STR^S : streptomycin susceptible; STR^R: streptomycin resistant; EMB^S: ethambutol susceptible; EMB^R : ethambutol resistant; AMK^S: amikacin susceptible; AMK^R: amikacin resistant; OFX^S: ofloxacin susceptible; OFX^R: ofloxacin resistant; XDR-TB: extensively drug-resistant TB.